Exposure to toxin in certain foods could cause testicular cancer

February 01, 2002

WINSTON-SALEM, N.C. - A Wake Forest University cancer researcher has proposed that a compound found in certain foods may be a cause of testicular cancer in young men.

Writing in the February issue of Cancer Causes and Control, Gary G. Schwartz, Ph.D., M.P.H., Ph.D., proposes that exposure to a common carcinogen called ochratoxin A during childhood or even before birth may set up the testes so that testicular growth during puberty triggers the launch of testicular cancer.

Ochratoxin A results from molds that grow in grains and coffee beans and is found in animals that consume moldy grain, especially pigs.

"Little is known about the etiology of testicular cancer, which is the most common cancer among young men," said Schwartz, associate professor of cancer biology and public health sciences. It strikes men mostly between 14 and 34. He said that epidemiologic data point to exposure either in the womb or early in life, "but the nature of the exposure is unknown."

Schwartz's new theory calls for a process that takes several steps. It begins with exposure to ochratoxin A during pregnancy or early childhood, which induces damage to testicular DNA. Ochratoxin A is transferred through the placenta to the fetus, and also is present in mothers' milk, so infants could be exposed through breastfeeding. The DNA changes remain dormant until testicular growth at puberty promotes these changes in testicular DNA into cancer.

Testicular cancer is primarily a disease of young white men, and it shows marked geographic variation. For instance, the incidence is higher among northern Europeans than central or southern Europeans. Schwartz noted that grains grown in northern Europe are more likely to be contaminated because weather conditions during harvest season promote mold.

The highest rate in Europe is in Denmark, 7.8 cases per 100,000 per year. Consumption of pork products in Denmark is among the highest in the world, and Danes also eat the most rye, the cereal grain that is most often contaminated by ochratoxin A.

Another interesting element: testicular cancer is more common among people of higher socioeconomic levels. These are the groups most likely to breastfeed.

"We propose that exposure to ochratoxin A contaminated food provides a coherent explanation for much of the descriptive epidemiology of testicular cancer," Schwartz said, adding that future studies of testicular cancer "should focus on breastfeeding practices and the consumption of ochratoxin A containing foods such as cereals, pork products, milk and coffee by mothers and their male children."

If all this turns out to be correct, Schwartz offers several possible solutions. Public health efforts may be able to reduce exposure to ochratoxin A. Alternatively, public health efforts may reduce the genotoxicity of ochratoxin A exposure. The toxicity of ochratoxin A could be reduced by giving pregnant women drugs like aspirin or indomethacin or vitamins A, C and E, he said.

"These agents, in animals at least, markedly reduce the DNA damage caused by ochratoxin A," Schwartz said. Aspartame, the artificial sweeter, is similar structurally to ochratoxin A, and is a potent ochratoxin A antagonist.
-end-
Contact: Robert Conn (rconn@wfubmc.edu), Jonnie Rohrer (jrohrer@wfubmc.edu) Jim Steele (jsteele@wfubmc.edu) at (336) 716-4587

Wake Forest Baptist Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.